Lobeglitazone, a type of thiazolidinedione (TZD), is a peroxisome proliferator-activated receptor gamma (PPARγ) ligand used to regulate glucose and lipid metabolism in type 2 diabetes [18]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.